Rhumbline Advisers PDL BIOPHARMA INC COM Transaction History

Rhumbline Advisers

612

Previous 612 -0.0%

Previous $0 NaN%

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	N/A	612 New	612 $0
Q4 2020 Feb 10, 2021	SELL	N/A	-197,055 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	N/A	-28,273 Reduced 12.55%	197,055 $621,000
Q2 2020 Aug 13, 2020	BUY	N/A	3,521 Added 1.59%	225,328 $656,000
Q1 2020 May 06, 2020	BUY	N/A	10,347 Added 4.89%	221,807 $625,000
Q4 2019 Feb 05, 2020	SELL	N/A	-236 Reduced 0.11%	211,460 $686,000
Q3 2019 Oct 23, 2019	BUY	N/A	15,035 Added 7.65%	211,696 $457,000
Q2 2019 Aug 14, 2019	SELL	N/A	-19,716 Reduced 9.11%	196,661 $618,000
Q1 2019 May 01, 2019	BUY	N/A	178 Added 0.08%	216,377 $805,000
Q4 2018 Jan 31, 2019	BUY	N/A	59,953 Added 38.37%	216,199 $627,000
Q3 2018 Nov 07, 2018	SELL	N/A	-1,350 Reduced 0.86%	156,246 $411,000
Q2 2018 Aug 06, 2018	SELL	N/A	-7,604 Reduced 4.6%	157,596 $369,000
Q1 2018 May 02, 2018	SELL	N/A	-5,916 Reduced 3.46%	165,200 $486,000
Q4 2017 Feb 09, 2018	SELL	N/A	-37,230 Reduced 17.87%	171,116 $469,000
Q3 2017 Nov 06, 2017	BUY	N/A	208,346	208,346 $706,000

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.